Abstract
First Glimpse on Real-World Efficacy Outcomes for 2000 Patients with Systemic Light Chain Amyloidosis in Europe: A Retrospective Observational Multicenter Study By the European Myeloma Network
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have